P16 INK4a immunocytochemistry/immunohistochemistry: Need for scoring uniformization to be clinically useful in gynecological pathology

Annals of Diagnostic Pathology

Volumn 16, Issue 5, 2012, Pages 422-426

  Van Bogaert, Louis Jacques ^a  

^a UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

Human papillomavirus; p16 INK4a; Preinvasive lesions; Review; Scoring; Uterine cervix

Indexed keywords

MESSENGER RNA; PROTEIN P16; VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; VIRUS RNA;

CANCER DIAGNOSIS; CANCER RISK; HIGH RISK PATIENT; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; UTERINE CERVIX CANCER; WART VIRUS; FEMALE; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PAPILLOMAVIRUS INFECTION; PRECANCER; PROGNOSIS; STANDARD; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROGNOSIS; RNA, VIRAL; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84866095668     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2012.03.006     Document Type: Review

References (54)

1. J.P.A. Baak, A.J. Kruse, and S.J. Robboy Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J Clin Pathol 59 2006 1017 1028
2. T. Cox, and J. Cuzick HPV DNA testing in cervical cancer screening: from evidence to policies Gynecol Oncol 103 2006 8 11
3. INH4a improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia Am J Surg Pathol 26 2002 1389 1399
4. INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia Am J Clin Pathol 133 2010 395 406
5. K. Kurian, and A. Al-Nafussi Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases J Clin Pathol 52 1999 112 117
6. H.O. Smith, M.F. Tiffany, and C.R. Qualls The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study Gynecol Oncol 78 2000 97 105
7. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 2001 276 284
8. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
9. N. Munoz, F.X. Bosch, and S. de Sanjose Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
10. J.L. Wang, B.Y. Zheng, and X.D. Li Predictive significance of the alterations of p16INK4a, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer Clin Cancer Res 10 2004 2407 2414
11. S.H. van den Burg, and J.M. Palefsky Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful J Transl Med 7 2009 108 116
12. J.L. Wang, B.Y. Zheng, and X.D. Li p16INK4a and p14ARF expression pattern by immunohistochemistry in human papilloma-virus related cervical neoplasia Mod Pathol 18 2005 629 637
13. L.J. van Bogaert Large loop excision of the transformation zone (LLETZ): a pathologic evaluation in the Limpopo Province S Afr J Gynecol Oncol 3 2011 1 4
14. S. Ghaem-Maghami, S. Sagi, and G. Majeed Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis Lancet Oncol 8 2007 985 993
15. E.J. Nam, J.W. Kim, and J.W. Hong Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection J Gynaecol Oncol 19 2008 162 168
16. S. Cecchini, F. Carozzi, and M. Confortini Persistent human papilloma virus infection as an indicator of risk recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure Tumori 90 2004 225 228
17. I. Alonso, A. Torné, and L.M. Puig-Tintoré High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing Am J Obstet Gynecol 197 2007 433 434
18. V. Houfflin Debarge, P. Collinet, and D. Vinatier Value of human papillomavirus testing after conisation by loop electrosurgical excision for high-grade squamous intraepithelial lesions Gynecol Oncol 90 2003 587 592
19. P. Leguevaque, S. Motton, and A. Decharme Predictors of recurrence in high-grade cervical lesions and plan of management Eur J Surg Oncol 36 2010 1073 1079
20. J. Verguts, B. Bronselaer, and G. Donders Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papilloma virus testing and age at conisation Br J Obstet Gynaecol 113 2006 1303 1307
21. R. Sankaranarayanan, B.M. Nen, and S.S. Shastri HPV screening for cervical cancer in rural India N Engl J Med 360 2009 1385 1394
22. A. Baloglu, D. Uysal, and Bezircioglu Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions Arch Gynecol Obstet 282 2010 69 73
23. C. Crum Detecting every genital papilloma virus infection. What does it mean? Am J Pathol 153 1998 1667 1671
24. G. Böhmer, J.C. van den Brule, and O. Brummer No confirmed case of human papillomavirus DNA-negative cervical intraepithelial grade 3 or invasive primary cancer of the uterine cervix among 511 patients Am J Obstet Gynecol 189 2003 118 120
25. W. Shi, H. Kato, and B. Perez-Ordonez Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma J Clin Oncol 27 2009 6213 6221
26. INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia Int J Gynecol Cancer 16 2006 347 353
27. INK4a, and early endocervical glandular neoplasia Hum Pathol 33 2002 899 904
28. G. Negri, E. Egarter-Vigl, and A. Kasal p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix and its precursors: an immunohistochemical study with immunocytochemical correlations Am J Surg Pathol 27 2003 187 193
29. INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix J Pathol 201 2003 535 543
30. D.C. Allred, J.M. Harvey, and M. Berardo Prognostic and predictive factors in breast cancer by immunohistochemistry Mod Pathol 11 1998 155 168
31. A. Wolff, M.E. Hammond, and J.N. Schwarz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
32. E. Gorsching, S.S. Jeffrey, and W. Meinerz Basal carcinoma of the breast revisited: an old entity with new interpretations J Clin Pathol 61 2008 553 560
33. G.A. Boulet, C.A. Horvath, and C.E. Depuydt Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression Eur J Cancer Prev 19 2010 35 41
34. A.E. Walts, and S. Bose p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia Hum Pathol 40 2009 957 964
35. INK4a immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis Cancer Treat Rev 35 2009 210 220
36. R. Nenutil, J. Smardova, and S. Pavlova Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry J Pathol 207 2005 251 259
37. INK4a overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women Pathol Res Pract 206 2010 550 555
38. J. Keating, A. Cviko, and S. Riethdorf Ki-67, cyclin E, and p16INK4a are complementary surrogate biomarkers for human papillomavirus-related cervical neoplasia Am J Surg Pathol 25 2001 884 891
39. K. Cuschieri, and N. Wentzensen HPV mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2008 2536 2545
40. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types Mod Pathol 16 2003 665 673
41. INK4A and pRb expression in cervical squamous and glandular neoplasia Hum Pathol 35 2004 689 696
42. S.H. Song, H.M. Park, and D.W. Eom The expression of p16(INK4a) and Ki-67 in relation to high-risk human papilloma virus viral load and residual disease after conisation with positive margins Int J Gynecol Cancer 17 2007 858 867
43. C.S. Kong, B.L. Balzer, and M.L. Troxell p16INK4a immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia Am J Surg Pathol 31 2007 33 43
44. M. Dray, P. Russell, and C. Dalrymple p16(INK4a) as a complementary marker of high-grade intraepitheila lesions of the uterine cervix. I. Experience with squamous lesions in 189 consecutive cervical biopsies Pathology 37 2005 112 124
45. I.Z. Yildiz, A. Usubütün, and P. Firat Efficiency of immunohistochemical p16 overexpression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature Pathol Res Pract 203 2007 445 449
46. N. Ozgul, G. Bozdayi, and G. Usubütün Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity? J Obstet Gynaecol Res 34 2008 875 881
47. R. Redman, I. Rufforny, and C. Liu The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix Arch Pathol Lab Med 132 2008 795 799
48. INH4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears J Clin Pathol 56 2003 56 63
49. X. Qiao, T.A. Bhuiya, and M. Spitzer Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis J Low Genit Tract Dis 9 2005 100 107
50. N.J. Mulvany, D.G. Allen, and S.M. Wilson Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies Pathology 40 2008 335 344
51. INH4a expression in cervical intraepithelial neoplasia of adolescents Mod Pathol 18 2005 267 273
52. S.C. Hill, S.J. Youde, and S. Man Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis J Immunol 174 2005 41 50
53. INK4a in liquid-based specimens (SurePath) as a marker of cervical dysplasia and neoplasia Diagn Cytopathol 27 2002 365 370
54. INK4a-stained cervical squamous cells in liquid-based cytology samples Cancer Cytopathol 105 2005 461 467